Document Detail


Effects of growth hormone and insulin-like growth factor I in experimental heart failure.
MedLine Citation:
PMID:  10990154     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
These studies suggest that IGF-I and GH have generally favourable effects on the failing heart. They further demonstrate the ability of the severely depressed and failing heart to respond to the trophic and inotropic effects of GH. There is, however, a need for a better understanding of the mechanism of the contractility effect, the character of the hypertrophy observed (whether it is a more favourable type than that secondary to mechanical overload) and the vascular actions, both trophic and vasodilatory. In addition, the degree to which high-dose ACE inhibition or angiotensin II receptor blockade may inhibit some of these effects requires further study. Finally, it is clear that additional experimental studies and clinical trials are needed to investigate the long-term effects of GH on morbidity and mortality in heart failure, as well as the possible side-effects and other actions, such as the potential of GH to enhance skeletal muscle size and strength.
Authors:
J Ross; T Ryoke
Related Documents :
2698944 - Renin inhibition with a-64662: effect on blood pressure and hormonal response in man.
2835134 - Pressor inhibition of angiotensin-induced acth secretion.
15998684 - Glucose-6 phosphate dehydrogenase deficiency decreases the vascular response to angiote...
9194514 - Effects of sc-52458, an angiotensin at1 receptor antagonist, in the dog.
12185424 - Bench testing of pressure support ventilation with three different generations of venti...
11753124 - Lung elastic recoil in acute and chronic asthma.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society     Volume:  8 Suppl B     ISSN:  1096-6374     ISO Abbreviation:  Growth Horm. IGF Res.     Publication Date:  1998 Apr 
Date Detail:
Created Date:  2000-10-04     Completed Date:  2000-10-04     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9814320     Medline TA:  Growth Horm IGF Res     Country:  SCOTLAND    
Other Details:
Languages:  eng     Pagination:  159-61     Citation Subset:  IM    
Affiliation:
Department of Medicine, University of California at San Diego, La Jolla 92093-0613, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cardiac Output / drug effects
Cardiomyopathy, Dilated / drug therapy,  physiopathology
Disease Models, Animal
Growth Hormone / pharmacology,  therapeutic use*
Heart / drug effects,  physiopathology
Heart Failure / drug therapy*,  physiopathology*
Humans
Insulin-Like Growth Factor I / pharmacology,  therapeutic use*
Myocardial Contraction / drug effects
Grant Support
ID/Acronym/Agency:
HL-53733/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
67763-96-6/Insulin-Like Growth Factor I; 9002-72-6/Growth Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hexarelin exhibits protective activity against cardiac ischaemia in hearts from growth hormone-defic...
Next Document:  Regulation of leukocyte function by nitric oxide donors: the effect of S-nitroso-thiol complexes.